IDL Biotech has now received its first order from the company's distributor in Uganda, Medilink Lab & Surgical Ltd. The order refers to TUBEX® TF, IDL Biotech's rapid test for typhoid fever. Uganda will thus be the third country in Africa to which the company...
IDL Biotech continues to expand in Africa. IDL Biotech has signed a distributor agreement with Res Health Consult Ltd covering Ghana. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on finding the right partners for...
IDL Biotech continues to expand in Africa. Today, IDL Biotech has signed a distributor agreement with Roi Scientific Ltd covering Rwanda, South Sudan and Somalia. The agreement covers the sale of TUBEX® TF. Since its launch in Africa, the company has focused on...
IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF. Read the press release here
IDL has signed a new distribution agreement in Uganda Read the press release here
Achieving accurate laboratory diagnosis of typhoid fever: a review and meta-analysis of TUBEX® TF clinical performance. Read the article here: Read the press release here:
On September 17, 2019, IDL Biotech will launch the company's rapid test for typhoid fever, TUBEX TF, in Kenya. Read more here
Typhoid fever is a water and food-borne infectious disease caused by the bacterium, Salmonella enterica. The World Health Organization identifies typhoid fever as a serious public health issue. There are an estimated 11-20 million new cases reported annually,...
TUBEX® is getting wider recognition and awareness Now on social Media. As an example has one of our partners, PT. Pacific Biotekindo Intralab during the autumn organized a photo contest named TUBEX® & Me among the users of TUBEX® TF in Indonesia....
